Reports Q4 revenue $11.40B, consensus $11.28B. “We finished 2024 with excellent financial performance, delivering strong growth on the top and bottom line in the fourth quarter,” said CEO Marc Casper. “We drove meaningful share gain and enabled the success of our customers, by leveraging our proven growth strategy and PPI Business System, capping off another year of differentiated performance. We are in a great position to deliver excellent performance in 2025 as we continue to create value for all of our stakeholders and build an even brighter future for our company.”
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TMO:
- Notable companies reporting before tomorrow’s open
- Is TMO a Buy, Before Earnings?
- U.S. places new export controls on biotech equipment, Reuters reports
- Thermo Fisher upgraded to Outperform from Market Perform at Bernstein
- Thermo Fisher Olink platform selected for UK Biobank Pharma Proteomics Project